Rezichem Health Care Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-12-2024
- Paid Up Capital ₹ 0.15 M
as on 09-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Rezichem Health Care
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Giri, Dharmendra Giri, and Amrendra Giri serve as directors at the Company.
- CIN/LLPIN
U51397BR2011PTC016740
- Company No.
016740
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Champaran, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rezichem Health Care Private Limited offer?
Rezichem Health Care Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Common Disease Medicines, Psoriasis Ointment, Nutraceuticals & Dietary Supplements, Dietary Supplements, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Rezichem Health Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Giri  | Managing Director | 17-Mar-2011 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dharmendra Giri | Director | 17-Mar-2011 | Current |
| Amrendra Giri | Director | 17-Mar-2011 | Current |
Financial Performance of Rezichem Health Care.
Rezichem Health Care Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rezichem Health Care?
In 2017, Rezichem Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rezichem Health Care?
Unlock and access historical data on people associated with Rezichem Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rezichem Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rezichem Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
